Form 4 for CRL Charles River Laboratories
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-14 · accession 0001127602-23-029809 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-12-18 | 2023-12-14 | CRL | Creamer Victoria L | EVP, CHRO | M - OptEx | $136.70 | +5,526 | 22.0K | +33% | +$755.4K |
| D | 2023-12-18 | 2023-12-14 | CRL | Creamer Victoria L | EVP, CHRO | S - Sale+OE | $225.00 | -5,526 | 16.5K | -25% | -$1.24M |
| DM | 2023-12-18 | 2023-12-14 | CRL | Creamer Victoria L | EVP, CHRO | M - OptEx | $0.00 | -5,526 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-14 | M | A | 3,381 | $144.67 | 19,887 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-14 | S | D | 5,526 | $225.00 | 16,506 | D | — | — | |
| 3 | Common | Common Stock | 2023-12-14 | M | A | 2,145 | $124.13 | 22,032 | D | — | — | |
| 4 | Derivative | Stock Options (Right to Buy) | 2023-12-14 | M | D | 2,145 | $0.00 | 0 | D | $124.13 · 2020-02-01 to 2024-02-01 | 2,145 Common Stock | |
| 5 | Derivative | Stock Options (Right to Buy) | 2023-12-14 | M | D | 3,381 | $0.00 | 0 | D | $144.67 · 2020-02-22 to 2024-02-22 | 3,381 Common Stock |